Annual CFI
-$54.90 M
-$47.62 M-654.38%
December 31, 2021
Summary
- As of February 10, 2025, CLBS annual cash flow from investing activities is -$54.90 million, with the most recent change of -$47.62 million (-654.38%) on December 31, 2021.
- During the last 3 years, CLBS annual CFI has fallen by -$50.19 million (-1066.26%).
Performance
CLBS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$2.26 M
-$23.37 M-91.18%
September 1, 2022
Summary
- As of February 10, 2025, CLBS quarterly cash flow from investing activities is $2.26 million, with the most recent change of -$23.37 million (-91.18%) on September 1, 2022.
- Over the past year, CLBS quarterly CFI has dropped by -$2.68 million (-54.23%).
Performance
CLBS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$38.26 M
-$2.68 M-6.54%
September 1, 2022
Summary
- As of February 10, 2025, CLBS TTM cash flow from investing activities is $38.26 million, with the most recent change of -$2.68 million (-6.54%) on September 1, 2022.
- Over the past year, CLBS TTM CFI has increased by +$108.71 million (+154.32%).
Performance
CLBS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CLBS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -654.4% | -54.2% | +154.3% |
| 3 y3 years | -1066.3% | -58.0% | +78.5% |
| 5 y5 years | -233.0% | +159.6% | +78.5% |
CLBS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -91.2% | -369.3% | -6.5% | -243.5% |
| 5 y | 5-year | -356.1% | at low | -91.2% | -2978.8% | -6.5% | -325.9% |
| alltime | all time | -233.0% | at low | -91.6% | -2978.8% | -7.3% | -325.9% |
Caladrius Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $2.26 M(-91.2%) | $38.26 M(-6.5%) |
| Jun 2022 | - | $25.63 M(-520.9%) | $40.94 M(+897.6%) |
| Mar 2022 | - | -$6.09 M(-137.0%) | $4.10 M(-107.5%) |
| Dec 2021 | -$54.90 M(+654.4%) | $16.46 M(+233.2%) | -$54.90 M(-22.1%) |
| Sep 2021 | - | $4.94 M(-144.1%) | -$70.44 M(-18.5%) |
| Jun 2021 | - | -$11.20 M(-82.8%) | -$86.43 M(+3.5%) |
| Mar 2021 | - | -$65.09 M(-7252.7%) | -$83.47 M(+1047.0%) |
| Dec 2020 | -$7.28 M(-134.0%) | $910.00 K(-108.2%) | -$7.28 M(+152.3%) |
| Sep 2020 | - | -$11.04 M(+33.9%) | -$2.88 M(-121.3%) |
| Jun 2020 | - | -$8.25 M(-174.3%) | $13.54 M(-43.1%) |
| Mar 2020 | - | $11.10 M(+109.4%) | $23.79 M(+11.0%) |
| Dec 2019 | $21.43 M(-555.3%) | $5.30 M(-1.4%) | $21.43 M(+42.3%) |
| Sep 2019 | - | $5.38 M(+167.4%) | $15.06 M(+179.2%) |
| Jun 2019 | - | $2.01 M(-77.0%) | $5.39 M(+3.3%) |
| Mar 2019 | - | $8.74 M(-920.0%) | $5.22 M(-211.0%) |
| Dec 2018 | -$4.71 M(-111.4%) | -$1.07 M(-75.2%) | -$4.71 M(-132.3%) |
| Sep 2018 | - | -$4.29 M(-333.3%) | $14.59 M(-3.3%) |
| Jun 2018 | - | $1.84 M(-254.7%) | $15.09 M(-62.5%) |
| Mar 2018 | - | -$1.19 M(-106.5%) | $40.25 M(-2.5%) |
| Dec 2017 | $41.27 M(-1548.5%) | $18.23 M(-580.7%) | $41.27 M(+83.4%) |
| Sep 2017 | - | -$3.79 M(-114.0%) | $22.50 M(-12.4%) |
| Jun 2017 | - | $27.00 M(<-9900.0%) | $25.68 M(-1399.9%) |
| Mar 2017 | - | -$171.30 K(-67.9%) | -$1.98 M(-30.7%) |
| Dec 2016 | -$2.85 M(-175.0%) | -$533.50 K(-12.9%) | -$2.85 M(-218.5%) |
| Sep 2016 | - | -$612.50 K(-7.0%) | $2.40 M(-1839.3%) |
| Jun 2016 | - | -$658.50 K(-37.0%) | -$138.20 K(-96.5%) |
| Mar 2016 | - | -$1.04 M(-122.1%) | -$3.95 M(-204.0%) |
| Dec 2015 | $3.80 M(-135.4%) | $4.72 M(-249.6%) | $3.80 M(-146.8%) |
| Sep 2015 | - | -$3.15 M(-29.5%) | -$8.11 M(+56.1%) |
| Jun 2015 | - | -$4.47 M(-166.7%) | -$5.20 M(+86.0%) |
| Mar 2015 | - | $6.70 M(-193.3%) | -$2.79 M(-74.0%) |
| Dec 2014 | -$10.74 M(+298.9%) | -$7.19 M(+2905.6%) | -$10.74 M(+103.0%) |
| Sep 2014 | - | -$239.20 K(-88.4%) | -$5.29 M(-7.7%) |
| Jun 2014 | - | -$2.07 M(+66.9%) | -$5.73 M(+47.8%) |
| Mar 2014 | - | -$1.24 M(-28.9%) | -$3.88 M(+44.1%) |
| Dec 2013 | -$2.69 M(-144.2%) | -$1.74 M(+156.3%) | -$2.69 M(-134.4%) |
| Sep 2013 | - | -$680.10 K(+216.3%) | $7.83 M(-3.8%) |
| Jun 2013 | - | -$215.00 K(+301.1%) | $8.14 M(+32.4%) |
| Mar 2013 | - | -$53.60 K(-100.6%) | $6.14 M(+0.9%) |
| Dec 2012 | $6.09 M(-396.3%) | $8.78 M(-2463.7%) | $6.09 M(-477.0%) |
| Sep 2012 | - | -$371.30 K(-83.2%) | -$1.61 M(-179.0%) |
| Jun 2012 | - | -$2.21 M(+1904.3%) | $2.05 M(+117.6%) |
| Mar 2012 | - | -$110.10 K(-110.3%) | $939.90 K(-145.7%) |
| Dec 2011 | -$2.05 M(-88.0%) | $1.07 M(-67.4%) | -$2.05 M(-77.7%) |
| Sep 2011 | - | $3.29 M(-199.3%) | -$9.21 M(-40.5%) |
| Jun 2011 | - | -$3.31 M(+6.7%) | -$15.49 M(-0.7%) |
| Mar 2011 | - | -$3.10 M(-49.0%) | -$15.59 M(-8.9%) |
| Dec 2010 | -$17.11 M | -$6.09 M(+103.9%) | -$17.11 M(+33.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$2.98 M(-12.6%) | -$12.80 M(+20.7%) |
| Jun 2010 | - | -$3.41 M(-26.1%) | -$10.60 M(+46.0%) |
| Mar 2010 | - | -$4.62 M(+159.6%) | -$7.26 M(+174.0%) |
| Dec 2009 | -$2.65 M(>+9900.0%) | -$1.78 M(+125.2%) | -$2.65 M(+210.5%) |
| Sep 2009 | - | -$790.40 K(+949.7%) | -$853.90 K(+866.0%) |
| Jun 2009 | - | -$75.30 K(+1221.1%) | -$88.40 K(+574.8%) |
| Mar 2009 | - | -$5700.00(-132.6%) | -$13.10 K(+33.7%) |
| Dec 2008 | -$9800.00(-106.4%) | $17.50 K(-170.3%) | -$9800.00(-105.1%) |
| Sep 2008 | - | -$24.90 K(<-9900.0%) | $192.50 K(+13.3%) |
| Jun 2008 | - | $0.00(-100.0%) | $169.90 K(+5.3%) |
| Mar 2008 | - | -$2400.00(-101.1%) | $161.40 K(+5.4%) |
| Dec 2007 | $153.10 K(-455.2%) | $219.80 K(-562.7%) | $153.10 K(-258.2%) |
| Sep 2007 | - | -$47.50 K(+458.8%) | -$96.80 K(+55.1%) |
| Jun 2007 | - | -$8500.00(-20.6%) | -$62.40 K(+15.8%) |
| Mar 2007 | - | -$10.70 K(-64.5%) | -$53.90 K(+24.8%) |
| Dec 2006 | -$43.10 K(<-9900.0%) | -$30.10 K(+129.8%) | -$43.20 K(+229.8%) |
| Sep 2006 | - | -$13.10 K(<-9900.0%) | -$13.10 K(<-9900.0%) |
| Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2005 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2005 | - | $0.00(0.0%) | $600.00(>+9900.0%) |
| Jun 2005 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $0.00(-100.0%) | -$2200.00(-33.3%) |
| Dec 2004 | -$3300.00(-100.4%) | $600.00(-200.0%) | -$3300.00(-101.9%) |
| Sep 2004 | - | -$600.00(-72.7%) | $171.10 K(-79.8%) |
| Jun 2004 | - | -$2200.00(+100.0%) | $846.70 K(-0.0%) |
| Mar 2004 | - | -$1100.00(-100.6%) | $846.90 K(-0.1%) |
| Dec 2003 | $847.40 K(-167.9%) | $175.00 K(-74.1%) | $847.40 K(-202.0%) |
| Sep 2003 | - | $675.00 K(<-9900.0%) | -$831.00 K(-44.7%) |
| Jun 2003 | - | -$2000.00(+233.3%) | -$1.50 M(+0.1%) |
| Mar 2003 | - | -$600.00(-100.0%) | -$1.50 M(+20.3%) |
| Dec 2002 | -$1.25 M(-443.7%) | -$1.50 M(<-9900.0%) | -$1.25 M(+229.5%) |
| Sep 2002 | - | $3800.00(>+9900.0%) | -$378.60 K(+8130.4%) |
| Jun 2002 | - | $0.00(-100.0%) | -$4600.00(-101.6%) |
| Mar 2002 | - | $252.20 K(-139.7%) | $287.10 K(-20.9%) |
| Dec 2001 | $362.90 K(-1534.4%) | -$634.60 K(-268.0%) | $363.00 K(-74.5%) |
| Sep 2001 | - | $377.80 K(+29.5%) | $1.43 M(-21.4%) |
| Jun 2001 | - | $291.70 K(-11.1%) | $1.82 M(+19.6%) |
| Mar 2001 | - | $328.10 K(-23.4%) | $1.52 M(-6096.4%) |
| Dec 2000 | -$25.30 K(-94.6%) | $428.40 K(-44.1%) | -$25.30 K(-94.4%) |
| Sep 2000 | - | $766.90 K(<-9900.0%) | -$453.70 K(-62.8%) |
| Jun 2000 | - | -$6300.00(-99.5%) | -$1.22 M(+0.5%) |
| Mar 2000 | - | -$1.21 M | -$1.21 M |
| Dec 1999 | -$464.40 K(-32.8%) | - | - |
| Dec 1998 | -$690.90 K(<-9900.0%) | - | - |
| Mar 1998 | $0.00(0.0%) | - | - |
| Mar 1997 | $0.00(-100.0%) | - | - |
| Mar 1996 | -$5900.00 | - | - |
FAQ
- What is Caladrius Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Caladrius Biosciences?
- What is Caladrius Biosciences annual CFI year-on-year change?
- What is Caladrius Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly CFI year-on-year change?
- What is Caladrius Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Caladrius Biosciences?
- What is Caladrius Biosciences TTM CFI year-on-year change?
What is Caladrius Biosciences annual cash flow from investing activities?
The current annual CFI of CLBS is -$54.90 M
What is the all time high annual CFI for Caladrius Biosciences?
Caladrius Biosciences all-time high annual cash flow from investing activities is $41.27 M
What is Caladrius Biosciences annual CFI year-on-year change?
Over the past year, CLBS annual cash flow from investing activities has changed by -$47.62 M (-654.38%)
What is Caladrius Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of CLBS is $2.26 M
What is the all time high quarterly CFI for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly cash flow from investing activities is $27.00 M
What is Caladrius Biosciences quarterly CFI year-on-year change?
Over the past year, CLBS quarterly cash flow from investing activities has changed by -$2.68 M (-54.23%)
What is Caladrius Biosciences TTM cash flow from investing activities?
The current TTM CFI of CLBS is $38.26 M
What is the all time high TTM CFI for Caladrius Biosciences?
Caladrius Biosciences all-time high TTM cash flow from investing activities is $41.27 M
What is Caladrius Biosciences TTM CFI year-on-year change?
Over the past year, CLBS TTM cash flow from investing activities has changed by +$108.71 M (+154.32%)